Compare IOP Reduction

15 products »

close Created with Sketch.

Xalatan

Pfizer Inc.

Xalatan (latanoprost ophthalmic solution) 0.005% is a prostaglandin F2? analogue indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

At-a-Glance
  • Mechanism of Action: Latanoprost is a prostanoid selective FP receptor agonist that is believed to reduce the intraocular pressure (IOP) by increasing the outflow of aqueous humor. Studies in animals and man suggest that the main mechanism of action is increased uveoscleral outflow.
  • Dosage: One drop in the affected eye(s) once-daily in the evening

Details

FDA

Yes

CE Mark

Not specified

Active Ingredients

Latanoprost

Application

Topical

Status

Prescription

Strength

0.005%

Company Information

Contact the company for additional information, availability, or pricing:

Pfizer Inc.

pfizer.com

235 East 42nd Street

New York, NY 10017